Andrew Singer

Dr Singer is a pollution scientist whose research focuses on understanding its effects on microbial ecology, ecosystem function, and human health. Singer's research frequently has a policy-relevance angle, such as characterising the nature and effects of large-scale pharmaceutical use (e.g., antivirals such as Tamiflu, and antibiotics) during an influenza pandemic, and the drivers of antibiotic and antifungal resistance in the environment and their implications for ecosystems and human health, especially during a pandemic. His research includes national and international studies on the environmental drivers of AMR, their relevance to human health and considerations for policymakers. Dr Singer is active in wastewater pollution and epidemiology, aiming to understand human behaviour and health through sewage analysis (e.g., pathogen incidence and prevalence, drug compliance). He also actively participates in debates over the funding models needed to reinvigorate the novel antibiotic pipeline.

Dr Singer has been professionally active in the arts for over two years. He has: 1) co-written a play with a professional theatre director and writer; 2) worked with multiple professional dramaturgs to refine the critically aclaimed (5*) science-themed play: Panacea (1) which follows on from the first run of the play, which was also well-received (1); 3) served as Executive Producer and stage manager for three runs of Panacea in London; 4) secured funding and Executive Produced a tour of Panacea in London, Birmingham and Liverpool; and 4) is currently writing two sequels to Panacea (II & III). He seeks further opportunities to merge theatre and science and share the challenges of academia and science with the public, including the science and its associated ethics.